Establishing secure connection…Loading editor…Preparing document…

Collaborative Research Agreement Document

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

Collaborative Research Agreement Document

This Collaborative Research Agreement ("Agreement") is entered into as of Effective Date: by and between Party A Name: and Party B Name: .

Recitals (WHEREAS)

WHEREAS, Party A has expertise and facilities in the area of research described as Project Title: ; and

WHEREAS, Party B possesses complementary expertise and agrees to collaborate with Party A to perform the research activities set forth herein under the terms and conditions of this Agreement; and

WHEREAS, the Parties intend to define their respective responsibilities, funding, handling of confidential information and ownership of results generated in connection with the collaboration.

1. Principal Investigators and Contacts

2. Scope of Work

The Parties shall cooperate to perform the research tasks, experiments and analyses described below. The Scope of Work will include specific tasks, deliverables, milestones and technical approaches.

3. Payment Terms

In consideration for performance of the Scope of Work, the funding provided by a Party or third party shall be as follows:

4. Term and Termination

This Agreement shall commence on Start Date: and shall continue until End Date: unless earlier terminated in accordance with this Section.

Either Party may terminate this Agreement for material breach by the other Party if such breach remains uncured for a period of Notice Period: days after written notice. Either Party may also terminate for convenience upon written notice to the other Party as agreed by the Parties in writing.

5. Confidentiality

Each Party may disclose Confidential Information to the other in connection with the Project. "Confidential Information" means non-public proprietary information disclosed in writing and marked confidential or, if disclosed orally, confirmed in writing within thirty (30) days. Recipient shall: (a) use Confidential Information only to perform its obligations under this Agreement; (b) restrict disclosure to employees, agents or subcontractors who have a need to know and are bound by confidentiality obligations no less protective than those in this Agreement; and (c) exercise at least the same degree of care to protect Confidential Information as it uses for its own confidential information but not less than reasonable care.

Exceptions to confidentiality obligations include information that: (i) is or becomes publicly known other than by breach of this Agreement; (ii) was rightfully received from a third party without restriction; (iii) was independently developed by Recipient; or (iv) is required to be disclosed by law, in which case Recipient shall provide prompt notice to Discloser to seek protective measures.

6. Intellectual Property

(a) Background Intellectual Property (Background IP) shall remain the sole property of the Party bringing such Background IP into the collaboration. Each Party grants the other a non-exclusive, non-transferable, royalty-free license to use Background IP solely to perform the Scope of Work.

(b) Intellectual Property developed or conceived jointly in the performance of the Project (Joint IP) shall be owned jointly by the inventing Parties in proportion to their inventive contribution, unless the Parties agree otherwise in writing. Patent prosecution, maintenance and enforcement of Joint IP shall be conducted by mutual agreement and costs shared as agreed.

7. Publication and Presentation

The Parties encourage timely publication of results. Prior to submission for publication, the Publishing Party shall provide the other Party with copies of proposed manuscripts and related materials and allow Review Period: days to review for Confidential Information or patentable subject matter. Review shall be limited to identification of Confidential Information or patent filing needs and shall not unreasonably delay publication.

8. Warranties, Limitation of Liability and Indemnity

Each Party represents that it has authority to enter into this Agreement. EXCEPT AS EXPRESSLY PROVIDED, ALL WARRANTIES ARE DISCLAIMED. Neither Party shall be liable for incidental or consequential damages except for damages arising from willful misconduct or gross negligence. Each Party shall indemnify and hold harmless the other from third-party claims arising from the indemnifying Party’s negligent acts or breach of this Agreement, subject to applicable law.

9. Governing Law

This Agreement shall be governed by and construed in accordance with the laws of the jurisdiction of , without regard to its conflicts of law principles.

10. Notices

All notices required or permitted under this Agreement shall be in writing and delivered to the addresses set forth below or such other address as either Party may designate by notice.

11. Entire Agreement

This Agreement constitutes the entire understanding between the Parties with respect to the subject matter hereof and supersedes all prior negotiations, understandings and agreements. Any amendment or modification must be in writing and signed by authorized representatives of both Parties.

12. Miscellaneous Provisions

If any provision of this Agreement is held invalid or unenforceable, the remainder shall continue in full force and effect. No Party may assign its rights or obligations without the prior written consent of the other Party, except to a successor in interest by merger or acquisition.

Party A:

By:

Date:

Party B:

By:

Date:

Enter text✕

What the Collaborative Research Agreement Document Is

A Collaborative Research Agreement Document is a written contract that defines a joint research relationship between two or more parties, such as universities, private companies, government labs, or nonprofit research organizations. It sets the project scope, roles and responsibilities, funding and budget terms, ownership and licensing of intellectual property, confidentiality and data‑sharing rules, publication rights, liability allocation, and dispute resolution procedures. The agreement also specifies reporting milestones, compliance with applicable laws and regulations, and execution mechanics including signing, delivery, and retention of the fully executed record.

Why a Clear Collaborative Research Agreement Matters

A clear agreement reduces misunderstanding, preserves each party’s IP rights, clarifies data sharing and privacy obligations, and establishes who controls publication and commercialization. It allocates risk and cost, creates enforceable milestones, and documents consent and authorization needed for regulatory compliance.

Why a Clear Collaborative Research Agreement Matters

Who Typically Uses This Agreement

Each participant should review responsibilities, authorizations, and signature authority before execution to avoid later disputes.

  • University research groups and technology transfer offices coordinating multi‑institution projects or student involvement.
  • Biotech and pharmaceutical companies collaborating with academic labs on preclinical or clinical research.
  • Government research agencies and national labs partnering with external contractors or universities.

Key Roles and Decision‑Makers

Principal Investigator

The lead researcher responsible for technical delivery and compliance with protocol terms. They ensure milestones, ethical approvals, and data management practices are followed and coordinate with institutional offices for IP and funding matters.

Legal / Tech Transfer

Office of sponsored programs, legal counsel, or technology transfer professionals who negotiate IP, publication, licensing, and indemnity terms and ensure institutional policies and sponsor requirements are satisfied.

Core Sections to Include in the Agreement

A professionally drafted Collaborative Research Agreement typically organizes terms into discrete sections so responsibilities, IP, confidentiality, and compliance are easy to locate and enforce.

Scope of Work

Describe tasks, deliverables, timelines, milestones, and performance metrics in precise, measurable language to reduce ambiguity during execution and review.

Intellectual Property

Allocate ownership and licensing of background and foreground IP, define invention disclosure procedures, and set rules for patent prosecution and commercialization.

Confidentiality

Specify what information is confidential, duration of confidentiality obligations, permitted disclosures, and procedures for handling inadvertent disclosures.

Data Management

Address data ownership, permitted uses, sharing, storage, anonymization, and compliance with privacy laws such as HIPAA or FERPA where applicable.

Publications

Define publication review periods, embargo options, authorship criteria, and sponsor‑review rights to balance academic freedom and commercial interests.

Funding and Budget

Specify payment schedule, milestone payments, allowable costs, indirect cost recovery, and audit and reporting obligations.

Step‑by‑Step: Preparing and Executing the Agreement

Follow these sequential steps from drafting through execution to ensure a compliant, enforceable agreement.

  • 01
    Draft the Agreement: Assemble SOW, budget, IP, data, and publication terms.
  • 02
    Internal Reviews: Circulate to PI, tech transfer, and compliance offices for comments.
  • 03
    Negotiate Terms: Resolve IP, liability, and publication items with counterparties.
  • 04
    Execute and Distribute: Obtain signatures, save executed copies, and notify stakeholders.

Routing and Submission Workflow

Typical routing ensures required reviewers see the document and signers receive a clear, auditable path to execution.

  • Review Cycle: Send draft to legal, finance, and PI for sequential review.
  • Prepare Final: Incorporate edits and lock final fields for signing.
  • Send to Signers: Deliver signing requests to authorized representatives.
  • Confirm Execution: Collect executed copies and distribute to all parties.

Digital Workflow Settings for eExecution

Configure document fields and authentication to match organizational policy and regulatory needs before sending for signature.

Field Configuration
Authentication Email link | SMS code or stronger as needed
Signature Fields Assign role-based signature and date fields
Conditional Clauses Use conditional fields for optional exhibits
Audit Trail Capture timestamps, IP addresses, and actions

Technical Requirements for Electronic Execution

Verify that the selected platform can provide a tamper‑evident signed PDF, retention of the audit trail, and any institutional BAA or data processing agreements required for regulated data.

  • File Formats: PDF, DOCX supported
  • Integrations: CRM and storage connectors
  • Authentication: Email, SMS, or stronger

Security and Compliance Considerations

Encryption: TLS 1.2/1.3 in transit; AES-256 at rest
Audit Trail: Tamper-evident timestamps and event logs
HIPAA: BAA available for protected health information
21 CFR Part 11: Support for FDA-regulated electronic records
SOC 2: SOC 2 Type II certification available
ISO: ISO 27001 certified information security

Penalties and Risks from Poorly Prepared Agreements

IP Disputes: Risk of ownership litigation and lost commercialization
HIPAA Violations: Civil penalties and corrective action requirements
Contract Damages: Breach claims, indemnity costs, and attorney fees
Invalid Signatures: Challenge to enforceability if ESIGN exceptions apply
Publication Delays: Sponsor review or authorship disputes slow dissemination
Data Loss: Regulatory fines and reputational harm from breaches

Common Mistakes to Avoid

  • Using vague scope language that leaves major deliverables undefined and invites disputes during performance.
  • Failing to specify ownership of background versus foreground intellectual property and resulting licensing terms.
  • Neglecting data privacy or HIPAA protections when research involves patient or sensitive personal data.
  • Allowing signatories without clear authority to bind the institution, risking unenforceable obligations.

Key Deadlines and Timing Considerations

Track effective dates, milestone deadlines, reporting cycles, publication review periods, and termination notice windows to remain compliant.

Effective Date Entry:

Use MM/DD/YYYY; governs start of obligations

Milestone Deadlines:

List deliverable dates and acceptance criteria clearly

Reporting Schedule:

Specify frequency and format of technical and financial reports

Publication Review Period:

Define sponsor review days, commonly 30–60 days

Termination Notice:

State required notice period for early termination

Milestone Sequence from Draft to Compliance

A numbered milestone sequence provides clarity on what happens at each phase from initiation through post‑execution obligations.

01

Drafting

Create versioned draft with SOW, budget, and IP terms

02

Institutional Review

Legal and compliance offices review and approve terms

03

Execution

Authorized signatories execute the finalized agreement

04

Post‑Execution Compliance

Maintain records, report milestones, and manage publications

How This Agreement Differs from Related Research Documents

Compare common agreement types to identify which instrument best fits the planned collaboration and desired rights allocation.

Type Primary focus
Collaborative Research Agreement joint research
Sponsored Research Agreement sponsor-funded outcomes
Material Transfer Agreement transfer materials
Non‑Disclosure Agreement confidentiality only

eSignature Pricing and Feature Comparison

Pricing and basic feature availability for representative eSignature vendors; place signNow first per platform comparison conventions.

signNow DocuSign Adobe Sign PandaDoc HelloSign
Starting Price $8/user/mo $15/user/mo $14/user/mo $19/user/mo $15/user/mo
Free Trial 7-day free trial, no card Varies by plan Varies by plan Varies by plan Varies by plan
Bulk Send Yes Yes Yes Yes No
Audit Trail Yes Yes Yes Yes Yes
HIPAA Compliant Yes Yes Yes No No

Frequently Asked Questions and Troubleshooting

Answers to common questions about using, signing, and preserving collaborative research agreements and related eSignature issues.


Need help? Contact support

be ready to get more
Join over 28 million airSlate SignNow users